Placebo | Selexipag | |
Subjects n | 10 | 33 |
Demographics | ||
Male/female | 2/8 (20.0/80.0) | 6/27 (18.2/81.8) |
Age yrs | 53.8±16.3 | 54.8±16.8 |
Weight kg | 70.6±13.9 | 68.7±12.4 |
Caucasian/other | 9/1 (90.0/10.0) | 29/4 (88.0/12.0) |
Aetiology of PAH | ||
Idiopathic PAH | 7 (70.0) | 24 (72.7) |
Hereditary PAH | 1 (10.0) | 1 (3.0) |
Anorexigen-induced PAH | 2 (6.1) | |
PAH-CTD | 2 (20.0) | 4 (12.1) |
PAH associated with congenial heart disease | 2 (6.1) |
Data are presented as n (%) or mean±sd, unless otherwise stated. CTD: connective tissue disease.